Global Biodefense Market Insights and Forecast to 2028

Publisher Name :
Date: 27-Jan-2022
No. of pages: 115
Inquire Before Buying

Biodefense market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Biodefense market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

- Anthrax

- Smallpox

- Botulism

- Radiation/Nuclear

- Others

Segment by Application

- US Military Market

- US Civilian Market

- Non - US Market

By Company

- Emergent Biosolutions

- Hytest

- GSK

- Sanofi

- PharmAthene

- Bavarian Nordic

- SIGA Technologies

- Arbutus Biopharma

- DynPort Vaccine

- Xoma Corporation

- Ichor Medical Systems

- Aeolus Pharmaceuticals

- Achaogen

- Elusys Therapeutics

- Dynavax Technologies

- Cleveland BioLabs

- Soligenix

- Alnylam Pharmaceuticals

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Global Biodefense Market Insights and Forecast to 2028

Table of Contents
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biodefense Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Anthrax
1.2.3 Smallpox
1.2.4 Botulism
1.2.5 Radiation/Nuclear
1.2.6 Others
1.3 Market by Application
1.3.1 Global Biodefense Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 US Military Market
1.3.3 US Civilian Market
1.3.4 Non - US Market
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Biodefense Market Perspective (2017-2028)
2.2 Biodefense Growth Trends by Region
2.2.1 Biodefense Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Biodefense Historic Market Size by Region (2017-2022)
2.2.3 Biodefense Forecasted Market Size by Region (2023-2028)
2.3 Biodefense Market Dynamics
2.3.1 Biodefense Industry Trends
2.3.2 Biodefense Market Drivers
2.3.3 Biodefense Market Challenges
2.3.4 Biodefense Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biodefense Players by Revenue
3.1.1 Global Top Biodefense Players by Revenue (2017-2022)
3.1.2 Global Biodefense Revenue Market Share by Players (2017-2022)
3.2 Global Biodefense Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biodefense Revenue
3.4 Global Biodefense Market Concentration Ratio
3.4.1 Global Biodefense Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biodefense Revenue in 2021
3.5 Biodefense Key Players Head office and Area Served
3.6 Key Players Biodefense Product Solution and Service
3.7 Date of Enter into Biodefense Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biodefense Breakdown Data by Type
4.1 Global Biodefense Historic Market Size by Type (2017-2022)
4.2 Global Biodefense Forecasted Market Size by Type (2023-2028)
5 Biodefense Breakdown Data by Application
5.1 Global Biodefense Historic Market Size by Application (2017-2022)
5.2 Global Biodefense Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Biodefense Market Size (2017-2028)
6.2 North America Biodefense Market Size by Type
6.2.1 North America Biodefense Market Size by Type (2017-2022)
6.2.2 North America Biodefense Market Size by Type (2023-2028)
6.2.3 North America Biodefense Market Share by Type (2017-2028)
6.3 North America Biodefense Market Size by Application
6.3.1 North America Biodefense Market Size by Application (2017-2022)
6.3.2 North America Biodefense Market Size by Application (2023-2028)
6.3.3 North America Biodefense Market Share by Application (2017-2028)
6.4 North America Biodefense Market Size by Country
6.4.1 North America Biodefense Market Size by Country (2017-2022)
6.4.2 North America Biodefense Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Biodefense Market Size (2017-2028)
7.2 Europe Biodefense Market Size by Type
7.2.1 Europe Biodefense Market Size by Type (2017-2022)
7.2.2 Europe Biodefense Market Size by Type (2023-2028)
7.2.3 Europe Biodefense Market Share by Type (2017-2028)
7.3 Europe Biodefense Market Size by Application
7.3.1 Europe Biodefense Market Size by Application (2017-2022)
7.3.2 Europe Biodefense Market Size by Application (2023-2028)
7.3.3 Europe Biodefense Market Share by Application (2017-2028)
7.4 Europe Biodefense Market Size by Country
7.4.1 Europe Biodefense Market Size by Country (2017-2022)
7.4.2 Europe Biodefense Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biodefense Market Size (2017-2028)
8.2 Asia-Pacific Biodefense Market Size by Type
8.2.1 Asia-Pacific Biodefense Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Biodefense Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Biodefense Market Share by Type (2017-2028)
8.3 Asia-Pacific Biodefense Market Size by Application
8.3.1 Asia-Pacific Biodefense Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Biodefense Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Biodefense Market Share by Application (2017-2028)
8.4 Asia-Pacific Biodefense Market Size by Region
8.4.1 Asia-Pacific Biodefense Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Biodefense Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Biodefense Market Size (2017-2028)
9.2 Latin America Biodefense Market Size by Type
9.2.1 Latin America Biodefense Market Size by Type (2017-2022)
9.2.2 Latin America Biodefense Market Size by Type (2023-2028)
9.2.3 Latin America Biodefense Market Share by Type (2017-2028)
9.3 Latin America Biodefense Market Size by Application
9.3.1 Latin America Biodefense Market Size by Application (2017-2022)
9.3.2 Latin America Biodefense Market Size by Application (2023-2028)
9.3.3 Latin America Biodefense Market Share by Application (2017-2028)
9.4 Latin America Biodefense Market Size by Country
9.4.1 Latin America Biodefense Market Size by Country (2017-2022)
9.4.2 Latin America Biodefense Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biodefense Market Size (2017-2028)
10.2 Middle East & Africa Biodefense Market Size by Type
10.2.1 Middle East & Africa Biodefense Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Biodefense Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Biodefense Market Share by Type (2017-2028)
10.3 Middle East & Africa Biodefense Market Size by Application
10.3.1 Middle East & Africa Biodefense Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Biodefense Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Biodefense Market Share by Application (2017-2028)
10.4 Middle East & Africa Biodefense Market Size by Country
10.4.1 Middle East & Africa Biodefense Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Biodefense Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Emergent Biosolutions
11.1.1 Emergent Biosolutions Company Details
11.1.2 Emergent Biosolutions Business Overview
11.1.3 Emergent Biosolutions Biodefense Introduction
11.1.4 Emergent Biosolutions Revenue in Biodefense Business (2017-2022)
11.1.5 Emergent Biosolutions Recent Developments
11.2 Hytest
11.2.1 Hytest Company Details
11.2.2 Hytest Business Overview
11.2.3 Hytest Biodefense Introduction
11.2.4 Hytest Revenue in Biodefense Business (2017-2022)
11.2.5 Hytest Recent Developments
11.3 GSK
11.3.1 GSK Company Details
11.3.2 GSK Business Overview
11.3.3 GSK Biodefense Introduction
11.3.4 GSK Revenue in Biodefense Business (2017-2022)
11.3.5 GSK Recent Developments
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Biodefense Introduction
11.4.4 Sanofi Revenue in Biodefense Business (2017-2022)
11.4.5 Sanofi Recent Developments
11.5 PharmAthene
11.5.1 PharmAthene Company Details
11.5.2 PharmAthene Business Overview
11.5.3 PharmAthene Biodefense Introduction
11.5.4 PharmAthene Revenue in Biodefense Business (2017-2022)
11.5.5 PharmAthene Recent Developments
11.6 Bavarian Nordic
11.6.1 Bavarian Nordic Company Details
11.6.2 Bavarian Nordic Business Overview
11.6.3 Bavarian Nordic Biodefense Introduction
11.6.4 Bavarian Nordic Revenue in Biodefense Business (2017-2022)
11.6.5 Bavarian Nordic Recent Developments
11.7 SIGA Technologies
11.7.1 SIGA Technologies Company Details
11.7.2 SIGA Technologies Business Overview
11.7.3 SIGA Technologies Biodefense Introduction
11.7.4 SIGA Technologies Revenue in Biodefense Business (2017-2022)
11.7.5 SIGA Technologies Recent Developments
11.8 Arbutus Biopharma
11.8.1 Arbutus Biopharma Company Details
11.8.2 Arbutus Biopharma Business Overview
11.8.3 Arbutus Biopharma Biodefense Introduction
11.8.4 Arbutus Biopharma Revenue in Biodefense Business (2017-2022)
11.8.5 Arbutus Biopharma Recent Developments
11.9 DynPort Vaccine
11.9.1 DynPort Vaccine Company Details
11.9.2 DynPort Vaccine Business Overview
11.9.3 DynPort Vaccine Biodefense Introduction
11.9.4 DynPort Vaccine Revenue in Biodefense Business (2017-2022)
11.9.5 DynPort Vaccine Recent Developments
11.10 Xoma Corporation
11.10.1 Xoma Corporation Company Details
11.10.2 Xoma Corporation Business Overview
11.10.3 Xoma Corporation Biodefense Introduction
11.10.4 Xoma Corporation Revenue in Biodefense Business (2017-2022)
11.10.5 Xoma Corporation Recent Developments
11.11 Ichor Medical Systems
11.11.1 Ichor Medical Systems Company Details
11.11.2 Ichor Medical Systems Business Overview
11.11.3 Ichor Medical Systems Biodefense Introduction
11.11.4 Ichor Medical Systems Revenue in Biodefense Business (2017-2022)
11.11.5 Ichor Medical Systems Recent Developments
11.12 Aeolus Pharmaceuticals
11.12.1 Aeolus Pharmaceuticals Company Details
11.12.2 Aeolus Pharmaceuticals Business Overview
11.12.3 Aeolus Pharmaceuticals Biodefense Introduction
11.12.4 Aeolus Pharmaceuticals Revenue in Biodefense Business (2017-2022)
11.12.5 Aeolus Pharmaceuticals Recent Developments
11.13 Achaogen
11.13.1 Achaogen Company Details
11.13.2 Achaogen Business Overview
11.13.3 Achaogen Biodefense Introduction
11.13.4 Achaogen Revenue in Biodefense Business (2017-2022)
11.13.5 Achaogen Recent Developments
11.14 Elusys Therapeutics
11.14.1 Elusys Therapeutics Company Details
11.14.2 Elusys Therapeutics Business Overview
11.14.3 Elusys Therapeutics Biodefense Introduction
11.14.4 Elusys Therapeutics Revenue in Biodefense Business (2017-2022)
11.14.5 Elusys Therapeutics Recent Developments
11.15 Dynavax Technologies
11.15.1 Dynavax Technologies Company Details
11.15.2 Dynavax Technologies Business Overview
11.15.3 Dynavax Technologies Biodefense Introduction
11.15.4 Dynavax Technologies Revenue in Biodefense Business (2017-2022)
11.15.5 Dynavax Technologies Recent Developments
11.16 Cleveland BioLabs
11.16.1 Cleveland BioLabs Company Details
11.16.2 Cleveland BioLabs Business Overview
11.16.3 Cleveland BioLabs Biodefense Introduction
11.16.4 Cleveland BioLabs Revenue in Biodefense Business (2017-2022)
11.16.5 Cleveland BioLabs Recent Developments
11.17 Soligenix
11.17.1 Soligenix Company Details
11.17.2 Soligenix Business Overview
11.17.3 Soligenix Biodefense Introduction
11.17.4 Soligenix Revenue in Biodefense Business (2017-2022)
11.17.5 Soligenix Recent Developments
11.18 Alnylam Pharmaceuticals
11.18.1 Alnylam Pharmaceuticals Company Details
11.18.2 Alnylam Pharmaceuticals Business Overview
11.18.3 Alnylam Pharmaceuticals Biodefense Introduction
11.18.4 Alnylam Pharmaceuticals Revenue in Biodefense Business (2017-2022)
11.18.5 Alnylam Pharmaceuticals Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Biodefense Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Anthrax
Table 3. Key Players of Smallpox
Table 4. Key Players of Botulism
Table 5. Key Players of Radiation/Nuclear
Table 6. Key Players of Others
Table 7. Global Biodefense Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 8. Global Biodefense Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Biodefense Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Biodefense Market Share by Region (2017-2022)
Table 11. Global Biodefense Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Biodefense Market Share by Region (2023-2028)
Table 13. Biodefense Market Trends
Table 14. Biodefense Market Drivers
Table 15. Biodefense Market Challenges
Table 16. Biodefense Market Restraints
Table 17. Global Biodefense Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Biodefense Revenue Share by Players (2017-2022)
Table 19. Global Top Biodefense by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biodefense as of 2021)
Table 20. Ranking of Global Top Biodefense Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Biodefense Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Biodefense Product Solution and Service
Table 24. Date of Enter into Biodefense Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Biodefense Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Biodefense Revenue Market Share by Type (2017-2022)
Table 28. Global Biodefense Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Biodefense Revenue Market Share by Type (2023-2028)
Table 30. Global Biodefense Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Biodefense Revenue Share by Application (2017-2022)
Table 32. Global Biodefense Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Biodefense Revenue Share by Application (2023-2028)
Table 34. North America Biodefense Market Size by Type (2017-2022) & (US$ Million)
Table 35. North America Biodefense Market Size by Type (2023-2028) & (US$ Million)
Table 36. North America Biodefense Market Size by Application (2017-2022) & (US$ Million)
Table 37. North America Biodefense Market Size by Application (2023-2028) & (US$ Million)
Table 38. North America Biodefense Market Size by Country (2017-2022) & (US$ Million)
Table 39. North America Biodefense Market Size by Country (2023-2028) & (US$ Million)
Table 40. Europe Biodefense Market Size by Type (2017-2022) & (US$ Million)
Table 41. Europe Biodefense Market Size by Type (2023-2028) & (US$ Million)
Table 42. Europe Biodefense Market Size by Application (2017-2022) & (US$ Million)
Table 43. Europe Biodefense Market Size by Application (2023-2028) & (US$ Million)
Table 44. Europe Biodefense Market Size by Country (2017-2022) & (US$ Million)
Table 45. Europe Biodefense Market Size by Country (2023-2028) & (US$ Million)
Table 46. Asia Pacific Biodefense Market Size by Type (2017-2022) & (US$ Million)
Table 47. Asia Pacific Biodefense Market Size by Type (2023-2028) & (US$ Million)
Table 48. Asia Pacific Biodefense Market Size by Application (2017-2022) & (US$ Million)
Table 49. Asia Pacific Biodefense Market Size by Application (2023-2028) & (US$ Million)
Table 50. Asia Pacific Biodefense Market Size by Region (2017-2022) & (US$ Million)
Table 51. Asia Pacific Biodefense Market Size by Region (2023-2028) & (US$ Million)
Table 52. Latin America Biodefense Market Size by Type (2017-2022) & (US$ Million)
Table 53. Latin America Biodefense Market Size by Type (2023-2028) & (US$ Million)
Table 54. Latin America Biodefense Market Size by Application (2017-2022) & (US$ Million)
Table 55. Latin America Biodefense Market Size by Application (2023-2028) & (US$ Million)
Table 56. Latin America Biodefense Market Size by Country (2017-2022) & (US$ Million)
Table 57. Latin America Biodefense Market Size by Country (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Biodefense Market Size by Type (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Biodefense Market Size by Type (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Biodefense Market Size by Application (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Biodefense Market Size by Application (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Biodefense Market Size by Country (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Biodefense Market Size by Country (2023-2028) & (US$ Million)
Table 64. Emergent Biosolutions Company Details
Table 65. Emergent Biosolutions Business Overview
Table 66. Emergent Biosolutions Biodefense Product
Table 67. Emergent Biosolutions Revenue in Biodefense Business (2017-2022) & (US$ Million)
Table 68. Emergent Biosolutions Recent Developments
Table 69. Hytest Company Details
Table 70. Hytest Business Overview
Table 71. Hytest Biodefense Product
Table 72. Hytest Revenue in Biodefense Business (2017-2022) & (US$ Million)
Table 73. Hytest Recent Developments
Table 74. GSK Company Details
Table 75. GSK Business Overview
Table 76. GSK Biodefense Product
Table 77. GSK Revenue in Biodefense Business (2017-2022) & (US$ Million)
Table 78. GSK Recent Developments
Table 79. Sanofi Company Details
Table 80. Sanofi Business Overview
Table 81. Sanofi Biodefense Product
Table 82. Sanofi Revenue in Biodefense Business (2017-2022) & (US$ Million)
Table 83. Sanofi Recent Developments
Table 84. PharmAthene Company Details
Table 85. PharmAthene Business Overview
Table 86. PharmAthene Biodefense Product
Table 87. PharmAthene Revenue in Biodefense Business (2017-2022) & (US$ Million)
Table 88. PharmAthene Recent Developments
Table 89. Bavarian Nordic Company Details
Table 90. Bavarian Nordic Business Overview
Table 91. Bavarian Nordic Biodefense Product
Table 92. Bavarian Nordic Revenue in Biodefense Business (2017-2022) & (US$ Million)
Table 93. Bavarian Nordic Recent Developments
Table 94. SIGA Technologies Company Details
Table 95. SIGA Technologies Business Overview
Table 96. SIGA Technologies Biodefense Product
Table 97. SIGA Technologies Revenue in Biodefense Business (2017-2022) & (US$ Million)
Table 98. SIGA Technologies Recent Developments
Table 99. Arbutus Biopharma Company Details
Table 100. Arbutus Biopharma Business Overview
Table 101. Arbutus Biopharma Biodefense Product
Table 102. Arbutus Biopharma Revenue in Biodefense Business (2017-2022) & (US$ Million)
Table 103. Arbutus Biopharma Recent Developments
Table 104. DynPort Vaccine Company Details
Table 105. DynPort Vaccine Business Overview
Table 106. DynPort Vaccine Biodefense Product
Table 107. DynPort Vaccine Revenue in Biodefense Business (2017-2022) & (US$ Million)
Table 108. DynPort Vaccine Recent Developments
Table 109. Xoma Corporation Company Details
Table 110. Xoma Corporation Business Overview
Table 111. Xoma Corporation Biodefense Product
Table 112. Xoma Corporation Revenue in Biodefense Business (2017-2022) & (US$ Million)
Table 113. Xoma Corporation Recent Developments
Table 114. Ichor Medical Systems Company Details
Table 115. Ichor Medical Systems Business Overview
Table 116. Ichor Medical Systems Biodefense Product
Table 117. Ichor Medical Systems Revenue in Biodefense Business (2017-2022) & (US$ Million)
Table 118. Ichor Medical Systems Recent Developments
Table 119. Aeolus Pharmaceuticals Company Details
Table 120. Aeolus Pharmaceuticals Business Overview
Table 121. Aeolus Pharmaceuticals Biodefense Product
Table 122. Aeolus Pharmaceuticals Revenue in Biodefense Business (2017-2022) & (US$ Million)
Table 123. Aeolus Pharmaceuticals Recent Developments
Table 124. Achaogen Company Details
Table 125. Achaogen Business Overview
Table 126. Achaogen Biodefense Product
Table 127. Achaogen Revenue in Biodefense Business (2017-2022) & (US$ Million)
Table 128. Achaogen Recent Developments
Table 129. Elusys Therapeutics Company Details
Table 130. Elusys Therapeutics Business Overview
Table 131. Elusys Therapeutics Biodefense Product
Table 132. Elusys Therapeutics Revenue in Biodefense Business (2017-2022) & (US$ Million)
Table 133. Elusys Therapeutics Recent Developments
Table 134. Dynavax Technologies Company Details
Table 135. Dynavax Technologies Business Overview
Table 136. Dynavax Technologies Biodefense Product
Table 137. Dynavax Technologies Revenue in Biodefense Business (2017-2022) & (US$ Million)
Table 138. Dynavax Technologies Recent Developments
Table 139. Cleveland BioLabs Company Details
Table 140. Cleveland BioLabs Business Overview
Table 141. Cleveland BioLabs Biodefense Product
Table 142. Cleveland BioLabs Revenue in Biodefense Business (2017-2022) & (US$ Million)
Table 143. Cleveland BioLabs Recent Developments
Table 144. Soligenix Company Details
Table 145. Soligenix Business Overview
Table 146. Soligenix Biodefense Product
Table 147. Soligenix Revenue in Biodefense Business (2017-2022) & (US$ Million)
Table 148. Soligenix Recent Developments
Table 149. Alnylam Pharmaceuticals Company Details
Table 150. Alnylam Pharmaceuticals Business Overview
Table 151. Alnylam Pharmaceuticals Biodefense Product
Table 152. Alnylam Pharmaceuticals Revenue in Biodefense Business (2017-2022) & (US$ Million)
Table 153. Alnylam Pharmaceuticals Recent Developments
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biodefense Market Share by Type: 2021 VS 2028
Figure 2. Anthrax Features
Figure 3. Smallpox Features
Figure 4. Botulism Features
Figure 5. Radiation/Nuclear Features
Figure 6. Others Features
Figure 7. Global Biodefense Market Share by Application: 2021 VS 2028
Figure 8. US Military Market Case Studies
Figure 9. US Civilian Market Case Studies
Figure 10. Non - US Market Case Studies
Figure 11. Biodefense Report Years Considered
Figure 12. Global Biodefense Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Biodefense Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Biodefense Market Share by Region: 2021 VS 2028
Figure 15. Global Biodefense Market Share by Players in 2021
Figure 16. Global Top Biodefense Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biodefense as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Biodefense Revenue in 2021
Figure 18. North America Biodefense Market Size YoY (2017-2028) & (US$ Million)
Figure 19. North America Biodefense Market Size Market Share by Type (2017-2028)
Figure 20. North America Biodefense Market Size Market Share by Application (2017-2028)
Figure 21. North America Biodefense Market Size Share by Country (2017-2028)
Figure 22. United States Biodefense Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Biodefense Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Biodefense Market Size YoY (2017-2028) & (US$ Million)
Figure 25. Europe Biodefense Market Size Market Share by Type (2017-2028)
Figure 26. Europe Biodefense Market Size Market Share by Application (2017-2028)
Figure 27. Europe Biodefense Market Size Share by Country (2017-2028)
Figure 28. Germany Biodefense Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. France Biodefense Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. U.K. Biodefense Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Italy Biodefense Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Russia Biodefense Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Nordic Countries Biodefense Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Biodefense Market Size YoY (2017-2028) & (US$ Million)
Figure 35. Asia Pacific Biodefense Market Size Market Share by Type (2017-2028)
Figure 36. Asia Pacific Biodefense Market Size Market Share by Application (2017-2028)
Figure 37. Asia Pacific Biodefense Market Size Share by Region (2017-2028)
Figure 38. China Biodefense Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Japan Biodefense Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. South Korea Biodefense Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Southeast Asia Biodefense Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. India Biodefense Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Australia Biodefense Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Latin America Biodefense Market Size YoY (2017-2028) & (US$ Million)
Figure 45. Latin America Biodefense Market Size Market Share by Type (2017-2028)
Figure 46. Latin America Biodefense Market Size Market Share by Application (2017-2028)
Figure 47. Latin America Biodefense Market Size Share by Country (2017-2028)
Figure 48. Mexico Biodefense Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Brazil Biodefense Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Biodefense Market Size YoY (2017-2028) & (US$ Million)
Figure 51. Middle East and Africa Biodefense Market Size Market Share by Type (2017-2028)
Figure 52. Middle East and Africa Biodefense Market Size Market Share by Application (2017-2028)
Figure 53. Middle East and Africa Biodefense Market Size Share by Country (2017-2028)
Figure 54. Turkey Biodefense Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Saudi Arabia Biodefense Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. UAE Biodefense Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. Emergent Biosolutions Revenue Growth Rate in Biodefense Business (2017-2022)
Figure 58. Hytest Revenue Growth Rate in Biodefense Business (2017-2022)
Figure 59. GSK Revenue Growth Rate in Biodefense Business (2017-2022)
Figure 60. Sanofi Revenue Growth Rate in Biodefense Business (2017-2022)
Figure 61. PharmAthene Revenue Growth Rate in Biodefense Business (2017-2022)
Figure 62. Bavarian Nordic Revenue Growth Rate in Biodefense Business (2017-2022)
Figure 63. SIGA Technologies Revenue Growth Rate in Biodefense Business (2017-2022)
Figure 64. Arbutus Biopharma Revenue Growth Rate in Biodefense Business (2017-2022)
Figure 65. DynPort Vaccine Revenue Growth Rate in Biodefense Business (2017-2022)
Figure 66. Xoma Corporation Revenue Growth Rate in Biodefense Business (2017-2022)
Figure 67. Ichor Medical Systems Revenue Growth Rate in Biodefense Business (2017-2022)
Figure 68. Aeolus Pharmaceuticals Revenue Growth Rate in Biodefense Business (2017-2022)
Figure 69. Achaogen Revenue Growth Rate in Biodefense Business (2017-2022)
Figure 70. Elusys Therapeutics Revenue Growth Rate in Biodefense Business (2017-2022)
Figure 71. Dynavax Technologies Revenue Growth Rate in Biodefense Business (2017-2022)
Figure 72. Cleveland BioLabs Revenue Growth Rate in Biodefense Business (2017-2022)
Figure 73. Soligenix Revenue Growth Rate in Biodefense Business (2017-2022)
Figure 74. Alnylam Pharmaceuticals Revenue Growth Rate in Biodefense Business (2017-2022)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed
  • Global Biodefense Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 135
    According to our LPI (LP Information) latest study, the global Biodefense market size was valued at US$ 1119.1 million in 2023. With growing demand in downstream market, the Biodefense is forecast to a readjusted size of US$ 1865.5 million by 2030 with a CAGR of 7.6% during review period. The research report highlights the growth potential of the global Biodefense market. Biodefense are expected to show stable growth in the future market. However, product differentiation, reducing costs,......
  • Global Military Aerospace Simulation and Training Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 133
    According to our LPI (LP Information) latest study, the global Military Aerospace Simulation and Training market size was valued at US$ 10720 million in 2023. With growing demand in downstream market, the Military Aerospace Simulation and Training is forecast to a readjusted size of US$ 15590 million by 2030 with a CAGR of 5.5% during review period. The research report highlights the growth potential of the global Military Aerospace Simulation and Training market. Military Aerospace Simu......
  • Global Shooting Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 129
    According to our LPI (LP Information) latest study, the global Shooting market size was valued at US$ 3522.7 million in 2023. With growing demand in downstream market, the Shooting is forecast to a readjusted size of US$ 5487 million by 2030 with a CAGR of 6.5% during review period. The research report highlights the growth potential of the global Shooting market. Shooting are expected to show stable growth in the future market. However, product differentiation, reducing costs, and suppl......
  • Global Unattended Ground Sensor Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 107
    According to our LPI (LP Information) latest study, the global Unattended Ground Sensor market size was valued at US$ 2040.6 million in 2023. With growing demand in downstream market, the Unattended Ground Sensor is forecast to a readjusted size of US$ 2847.6 million by 2030 with a CAGR of 4.9% during review period. The research report highlights the growth potential of the global Unattended Ground Sensor market. Unattended Ground Sensor are expected to show stable growth in the future m......
  • Global Autonomous Underwater Vehicles (AUV) Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 117
    Market Overview of Global Autonomous Underwater Vehicles (AUV) market: According to our latest research, the global Autonomous Underwater Vehicles (AUV) market looks promising in the next 5 years. As of 2022, the global Autonomous Underwater Vehicles (AUV) market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and ......
  • Global Autonomous Underwater Vehicles Market Research Report 2023, Forecast to 2028
    Published: 28-Dec-2023        Price: US 2680 Onwards        Pages: 162
    An autonomous underwater vehicle is a robot that travels underwater without requiring input from an operator. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and m......
  • Global Autonomous Underwater Vehicles Professional Survey Report 2023, Forecast to 2028
    Published: 28-Dec-2023        Price: US 3280 Onwards        Pages: 109
    An autonomous underwater vehicle is a robot that travels underwater without requiring input from an operator. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and m......
  • Global Counter Unmanned Aerial Vehicle Defense System Market Research Report 2023, Forecast to 2028
    Published: 21-Dec-2023        Price: US 2680 Onwards        Pages: 179
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
  • Global Counter Unmanned Aerial Vehicle Defense System Professional Survey Report 2023, Forecast to 2028
    Published: 21-Dec-2023        Price: US 3280 Onwards        Pages: 139
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs